Parnell Pharmaceuticals Holdings Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2009

Location

Overland Park KS US

Primary Industry

Pharmaceuticals

About

Founded in 2009 and based in Kansas, US, Parnell Pharmaceuticals Holdings Ltd. operates as a veterinary pharmaceutical company. In February 2021, DW Healthcare Partners acquired the company. Parnell Pharmaceuticals Holdings operates as a contract manufacturer of FDA-approved animal sterile injectables and supplements under its brands estroPLAN, GONAbreed, and PROcept in the US, Australia, Canada, Middle East, and Asia-Pacific regions. The company's products are used for the dairy production of cattle and cows, joint care for horses, and dietary supplements for dogs. Parnell Pharmaceuticals Holdings generates revenue from its contract manufacturing services and sales of its products from its website.

Current Investors

DW Healthcare Partners

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pet Products, Health Foods & Nutritional Supplements, Pharmaceutical Research & Development, Internet

Website

www.parnell.com

Verticals

E-commerce

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2012

31 Dec 2013

30 Jun 2014

7,542,600

(7,115,133)

(94.3%)

(5,860,098)

(77.7%)

(17,333,322)

(229.8%)

31 Dec 2014

3,662,452

(1,136,296)

(31%)

(444,534)

(12.1%)

(1,428,522)

(39%)

31 Dec 2015

13,169,753

(12,459,321)

(94.6%)

(10,980,758)

(83.4%)

(13,737,532)

(104.3%)

31 Dec 2016

31 Dec 2017

31 Dec 2018

Unlock the recent years of financials and more for Parnell Pharmaceuticals Holdings Ltd..

Request a demo to see more.

Deals

Deals Type
Buyout

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Parnell Pharmaceuticals Holdings Ltd.	16 Nov 2020

Displaying 1-1 of 1

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.